|
|
|
|
Single-dose pharmacokinetics of VIR-3434, a novel neutralizing
monoclonal antibody, in participants with chronic hepatitis B virus infection
|
|
|
EASL 2023 June 21-24 Vienna
Sneha V. Gupta1, Sophia Elie1, Andre Arizpe1, George Hristopoulos1, Pan Wu1, Daniel Cloutier1, Maribel Reyes1
1Vir Biotechnology, Inc., San Francisco, CA
|
|
|
|
|
|
|